PO.ADV01 · 患者倡导

从生存者到合作伙伴:将患者声音贯穿于癌症研究全过程

From survivor to partner: integrating patient voice across the cancer research continuum

海报缩略图:从生存者到合作伙伴:将患者声音贯穿于癌症研究全过程
编号 ADV19 展板 19 时间 4/20 02:00–05:00 区域 Section 5 主讲 Jacqueline Smith
分会场 Advocates Poster Session 1
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

JACQUELINE Smith

Ovarian Cancer Alliance of San Diego, Rancho Santa Fe, CA

摘要 Abstract

中文摘要
从实验台到临床,癌症研究将科学创新转化为患者护理——然而,将患者声音贯穿于这一全过程需要研究文化的转变。对于那些选择超越生存者身份、投身倡导的人来说,患者合作伙伴这一角色将亲身经历转化为一种科学资产,放大了从发现到护理的影响力。 临床结局是癌症研究的基石——然而治疗所带来的代价远不止于此——包括身体、心理、经济以及照护者负担。患者合作伙伴将这些维度置于最前沿,确保研究反映癌症治疗的全部人类代价。他们的贡献贯穿研究全过程——从研究设计和经费申请,到临床试验招募和研究结果的传播——并进一步延伸至政策和立法倡导以及筹款领域。 要充分发挥这种合作关系的潜力,必须直面真实存在的障碍:沟通鸿沟、结构性排斥以及优先事项的差异。弥合这些障碍需要共同的承诺——研究人员以通俗易懂的语言进行沟通;患者合作伙伴加深对科学过程的理解。最终,这将产生反映现实需求、赢得公众信任并为其所服务对象带来有意义变革的研究。 对患者合作伙伴而言,这不仅仅是贡献。这是能动性。这是希望。
查看英文原文 English abstract
From bench to bedside, cancer research translates scientificinnovation into patient care - yet integrating the patient voice across thatcontinuum requires a shift in research culture. For those who choose to movebeyond survivorship into advocacy, the role of patient partner transformslived experience into a scientific asset, amplifying impact from discovery tocare.Clinical outcomes are the cornerstone of cancer research -yet treatment carries costs that extend far beyond - physical, psychological,economic, and caregiver burden. Patient partners bring these dimensions to theforefront, ensuring research reflects the full human cost of cancer treatment.Their contributions span the research process - from study design and grantapplications to clinical trial recruitment and dissemination of findings -while extending beyond into policy and legislative advocacy and fundraising.Realizing the full potential of this partnership demandsconfronting real barriers: communication gaps, structural exclusion, anddiffering priorities. Bridging these requires shared commitment - researcherscommunicating in lay terms; patient partners deepening their understanding ofthe scientific process. Ultimately, this produces research that reflectsreal-world needs, earns public trust, and drives meaningful change for those itis meant to serve.For patient partners, this is more than contribution. It isagency. It is hope.

← 返回 AACR 2026 检索